Idenix Pharmaceuticals to Present at the Third Annual JMP Securities Healthcare Focus Conference

CAMBRIDGE, Mass., Sept. 29 IdenixPharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix managementwill present a corporate overview at the 2008 Third Annual JMP SecuritiesHealthcare Focus Conference on Monday, October 6, 2008 at 4:00 p.m. ET at LeParker Meridien in Manhattan.

The live and archived webcast of the company presentation can be accessedunder "Calendar of Events" in the Idenix Investor Center athttp://www.idenix.com. Please log in approximately 5-10 minutes before theevent to ensure a timely connection. The archived replays will be availableon the Idenix website for weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,is a biopharmaceutical company engaged in the discovery and development ofdrugs for the treatment of human viral and other infectious diseases. Idenix'scurrent focus is on the treatment of infections caused by the hepatitis Cvirus and HIV. For further information about Idenix, please refer tohttp://www.idenix.com.

Idenix Pharmaceuticals Contacts:

Amy Sullivan 617-995-9838 (investors)

Teri Dahlman 617-995-9905 (media)

SOURCE Idenix Pharmaceuticals, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...